These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 17113733

  • 1. Influence of carrier on the performance of dry powder inhalers.
    Saint-Lorant G, Leterme P, Gayot A, Flament MP.
    Int J Pharm; 2007 Apr 04; 334(1-2):85-91. PubMed ID: 17113733
    [Abstract] [Full Text] [Related]

  • 2. The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers.
    Flament MP, Leterme P, Gayot A.
    Int J Pharm; 2004 May 04; 275(1-2):201-9. PubMed ID: 15081150
    [Abstract] [Full Text] [Related]

  • 3. In vitro evaluation of powders for inhalation: the effect of drug concentration on particle detachment.
    Le VN, Hoang Thi TH, Robins E, Flament MP.
    Int J Pharm; 2012 Mar 15; 424(1-2):44-9. PubMed ID: 22207163
    [Abstract] [Full Text] [Related]

  • 4. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    Le VN, Bierend H, Robins E, Steckel H, Flament MP.
    Int J Pharm; 2012 Jan 17; 422(1-2):75-82. PubMed ID: 22036653
    [Abstract] [Full Text] [Related]

  • 5. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH, Danède F, Descamps M, Flament MP.
    Eur J Pharm Biopharm; 2008 Sep 17; 70(1):380-8. PubMed ID: 18504120
    [Abstract] [Full Text] [Related]

  • 6. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 7. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M, Kamplade J, Fakner P, Urbanetz NA, Walzel P, Steckel H, Scherließ R.
    Int J Pharm; 2017 May 30; 524(1-2):351-363. PubMed ID: 28347847
    [Abstract] [Full Text] [Related]

  • 8. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO, Molokhia AM, Elsayed MM.
    Eur J Pharm Biopharm; 2015 Oct 30; 96():291-303. PubMed ID: 26275831
    [Abstract] [Full Text] [Related]

  • 9. Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.
    Le VN, Robins E, Flament MP.
    Eur J Pharm Biopharm; 2010 Nov 30; 76(3):464-9. PubMed ID: 20854906
    [Abstract] [Full Text] [Related]

  • 10. Alternative sugars as potential carriers for dry powder inhalations.
    Steckel H, Bolzen N.
    Int J Pharm; 2004 Feb 11; 270(1-2):297-306. PubMed ID: 14726144
    [Abstract] [Full Text] [Related]

  • 11. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M, Kappl M, Butt HJ, Urbanetz NA, Lippold BC.
    Eur J Pharm Biopharm; 2007 Sep 11; 67(2):579-86. PubMed ID: 17418548
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H, Palakodaty S, Clark A, York P, Tzannis ST.
    Int J Pharm; 2004 Aug 20; 281(1-2):55-66. PubMed ID: 15288343
    [Abstract] [Full Text] [Related]

  • 13. Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.
    Littringer EM, Mescher A, Schroettner H, Achelis L, Walzel P, Urbanetz NA.
    Eur J Pharm Biopharm; 2012 Sep 20; 82(1):194-204. PubMed ID: 22595133
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
    Jones MD, Buckton G.
    Int J Pharm; 2016 Jul 25; 509(1-2):419-430. PubMed ID: 27265314
    [Abstract] [Full Text] [Related]

  • 15. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
    Kaialy W, Martin GP, Larhrib H, Ticehurst MD, Kolosionek E, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2012 Jan 01; 89():29-39. PubMed ID: 21962946
    [Abstract] [Full Text] [Related]

  • 16. Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations.
    Guchardi R, Frei M, John E, Kaerger JS.
    Int J Pharm; 2008 Feb 04; 348(1-2):10-7. PubMed ID: 17689898
    [Abstract] [Full Text] [Related]

  • 17. Effect of carrier particle shape on dry powder inhaler performance.
    Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A.
    Int J Pharm; 2011 Dec 12; 421(1):12-23. PubMed ID: 21945739
    [Abstract] [Full Text] [Related]

  • 18. The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.
    Young PM, Chan HK, Chiou H, Edge S, Tee TH, Traini D.
    J Pharm Sci; 2007 May 12; 96(5):1331-41. PubMed ID: 17455362
    [Abstract] [Full Text] [Related]

  • 19. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

  • 20. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.